These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29659348)

  • 1. Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).
    Sahin N; Altun H; Kurutaş EB; Fındıklı E
    Bosn J Basic Med Sci; 2018 May; 18(2):126-131. PubMed ID: 29659348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased levels of G protein-coupled estrogen receptor in children with autism spectrum disorders.
    Altun H; Kurutaş EB; Şahin N; Sınır H; Fındıklı E
    Psychiatry Res; 2017 Nov; 257():67-71. PubMed ID: 28734238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER-1 and sex-hormone levels in patients with otosclerosis.
    Erdem D; Şevik Eliçora S; Güven B; Dinç AE
    Am J Otolaryngol; 2020; 41(3):102442. PubMed ID: 32144019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of G-protein coupled membrane estrogen receptor-1 level in stuttering.
    Bilal N; Kurutas EB; Orhan I
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):469-476. PubMed ID: 29299745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of GPER gene polymorphism with social function of children with attention deficit hyperactivity disorder].
    Xiao G; Zhou X; Huang J; Chen Q; Li H; Zhao Y; Hu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):587-590. PubMed ID: 30098262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum G protein-coupled estrogen receptor 1 (GPER-1) levels in patients with androgenetic alopecia.
    Öztürk P; Kurutas EB; Kuş MM
    Arch Dermatol Res; 2022 Sep; 314(7):681-685. PubMed ID: 34297198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder.
    Baykal S; Albayrak Y; Durankuş F; Güzel S; Abbak Ö; Potas N; Beyazyüz M; Karabekiroğlu K; Donma MM
    Neurol Sci; 2019 Mar; 40(3):593-602. PubMed ID: 30617449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
    Bilgiç A; Toker A; Işık Ü; Kılınç İ
    Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum nerve growth factor (NGF) levels in children with attention deficit/hyperactivity disorder (ADHD).
    Guney E; Ceylan MF; Kara M; Tekin N; Goker Z; Senses Dinc G; Ozturk O; Eker S; Kizilgun M
    Neurosci Lett; 2014 Feb; 560():107-11. PubMed ID: 24361544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum thioredoxin levels are not correlated with executive functions in children with attention deficit hyperactivity disorder.
    Guney E; Buyuktaskin D; Tas Torun Y; Arslan B; Gulbahar O; Ozaslan A; Isik Taner Y; Iseri E
    Neurosci Lett; 2019 Jul; 705():118-123. PubMed ID: 31028843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered serum levels of vascular endothelial growth factor and glial-derived neurotrophic factor but not fibroblast growth factor-2 in treatment-naive children with attention deficit/hyperactivity disorder.
    Yurteri N; Şahin İE; Tufan AE
    Nord J Psychiatry; 2019; 73(4-5):302-307. PubMed ID: 31170860
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Percinel I; Yazici KU; Ustundag B
    Child Psychiatry Hum Dev; 2016 Apr; 47(2):259-69. PubMed ID: 26092605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet serotonin concentration in children with attention-deficit/hyperactivity disorder.
    Hercigonja Novkovic V; Rudan V; Pivac N; Nedic G; Muck-Seler D
    Neuropsychobiology; 2009; 59(1):17-22. PubMed ID: 19221444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased zonulin is associated with hyperactivity and social dysfunctions in children with attention deficit hyperactivity disorder.
    Özyurt G; Öztürk Y; Appak YÇ; Arslan FD; Baran M; Karakoyun İ; Tufan AE; Pekcanlar AA
    Compr Psychiatry; 2018 Nov; 87():138-142. PubMed ID: 30414552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of serum oxytocin in pediatric patients with Attention Deficit/Hyperactivity Disorder.
    Sasaki T; Hashimoto K; Oda Y; Ishima T; Kurata T; Takahashi J; Kamata Y; Kimura H; Niitsu T; Komatsu H; Ishikawa M; Hasegawa T; Shiina A; Hashimoto T; Kanahara N; Shiraishi T; Iyo M
    Psychiatry Res; 2015 Aug; 228(3):746-51. PubMed ID: 26168929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder.
    Hekim Bozkurt Ö; Güney E; Göker Z; Şenses Dinç G; Alışık M; Erel Ö; Çöp E; Üneri ÖŞ
    Turk Psikiyatri Derg; 2018; 29(1):31-35. PubMed ID: 29730872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder.
    Bilgiç A; Toker A; Uysal S
    Psychiatry Clin Neurosci; 2016 Oct; 70(10):442-447. PubMed ID: 27283127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder.
    Işık Ü; Bilgiç A; Toker A; Kılınç I
    Psychiatry Res; 2018 Mar; 261():212-219. PubMed ID: 29324397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein-coupled estrogen receptor 1 (GPER 1) mediates estrogen-induced, proliferation of leiomyoma cells.
    Jiang X; Ye X; Ma J; Li W; Wu R; Jun L
    Gynecol Endocrinol; 2015; 31(11):894-8. PubMed ID: 26416628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein-coupled estrogen receptor activation improves contractile and diastolic functions in rat renal interlobular artery to protect against renal ischemia reperfusion injury.
    Chang Y; Han Z; Zhang Y; Zhou Y; Feng Z; Chen L; Li X; Li L; Si JQ
    Biomed Pharmacother; 2019 Apr; 112():108666. PubMed ID: 30784936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.